Month over Month Growth of 336% and 54% Reduction in Customer Acquisition Cost (CAC) DALLAS, TX, Feb. 19, 2026 (GLOBE ...

HIMS fourth-quarter 2025 results are likely to benefit from new specialties and global expansion, but higher costs and GLP-1 ...

Shares of Mangoceuticals Inc MGRX, which sells men's health products under the MangoRx brand, are trading sharply higher Friday afternoon after the company reported momentum for its $99-per-month ...

Carrot will integrate Blueberry Pediatrics' 24/7 pediatric telehealth and home diagnostic kits into its employer fertility ...

The largest recipient of donations from Palantir employees and the company’s PAC are PAC’s set up to support Trump. All you ...

In the column Straight Nonsense, columnist Moises Mendez II takes a queer eye to the insanity of straight culture.

UK testosterone prescriptions rose 135% amid falling sexual activity. Patients report benefits but side effects exist.

Dr. Raza Bokhari, Exec Chairman & CEO, Interviewed by Bloomberg Open Interest Anchor Matt Miller PHILADELPHIA, PA / ACCESS Newswire / February 12, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) (“Medicus” ...

Hims & Hers Health, Inc. faces volatile earnings as compounded GLP-1 setbacks pressure shares. Click for this HIMS stock ...

At $16, Hims & Hers Health stock is cheap on sales metrics, but upside is capped pending regulatory clarity and proof of ...

Before Yezan Salamoun was a University of Kansas PhD student working to advance a daily oral testosterone therapy, he was a pharmacist. Salamoun’s desire to help others took a new direction when he ...